SCHEMBL7242525

SCHEMBL7242525

Nc1ccc(-c2ccc(Cl)c(Cl)c2)cc1N1CCNCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 3/20 0.53
HTR1A P08908 3/20 0.46
HTR3A P46098 3/20 0.46
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
AHR P35869 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPK1 P28482 2/20 0.42
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
HTR6 P50406 4/20 0.41
HTR7 P34969 6/20 0.41
HTR2A P28223 2/20 0.41
HTR5A P47898 2/20 0.41
NCF1 P14598 1/20 0.40
HTR2B P41595 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3D Q70Z44 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6629232 0.88 ADRB1 (0.53) ADRB1HTR1AHTR3ADRD2DRD3
SCHEMBL7248902 0.78 ADRB1 (0.43) ADRB1HTR1AHTR3ADRD2DRD3
SCHEMBL6651477 0.76 ADRB1 (0.47) ADRB1HTR1AHTR3A
SCHEMBL7805793 0.75 GAA (0.46) ADRB1HTR1ADRD2DRD3ALDH1A1
SCHEMBL6782999 0.73 ADRB1 (0.53) ADRB1AHRALDH1A1CYP3A4LMNA
SCHEMBL25870816 0.72 ADRB1 (0.41) ADRB1HTR3ADRD2DRD3ALDH1A1
SCHEMBL6629435 0.72 ADORA3 (0.46) ADRB1ALDH1A1CYP3A4MEN1LMNA
SCHEMBL7242984 0.71 HTT (0.49) ADRB1HTR1AHTR3ADRD2DRD3
SCHEMBL459418 0.70 ADRB1 (0.52) ADRB1HTR1AHTR3ADRD2DRD3
SCHEMBL6128549 0.70 ALDH1A1 (0.68) ADRB1HTR1AHTR3ADRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030095958-A1 Inhibitors of bace VERTEX PHARMACEUTICALS INCORPORATED 2003-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030095958-A1 Inhibitors of bace BACE2, BACE1, APP ADRB1 3834/4885HTR1A 4154/4885HTR3A 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.